| This article has been cited by |
| 1 | Overview of Myasthenia Gravis Subgroups and its influence on Pregnancy and their Treatment Advances | |
| Ankita Wal,Pranay Wal,Ashutosh Pandey,Himangi Vig,Akash Ved,Himanshu Bhusan Samal |
| Pharmacophore.2022;13(3)19 |
| [DOI] |
|
| 2 | Overview of Myasthenia Gravis Subgroups and its influence on Pregnancy and their Treatment Advances | |
| Chiara Robba,Valeria Spennati,Sharon Einav,Federico Bilotta |
| Pharmacophore.2020;13(3)363 |
| [DOI] |
|
| 3 | Myasthenia gravis in pregnancy – a multidisciplinary approach | |
| Valentin Varlas,Roxana Georgiana Bors,Alexandru Baros,Monica Mihaela Cîrstoiu,Francesca Frîncu,Andreea Carp-Veliscu,Claudia Mehedintu |
| Obstetrica si Ginecologia.2022;2(70)18 |
| [DOI] |
|
| 4 | Clinical and pathophysiologic relevance of autoantibodies in neonatal myasthenia gravis | |
| Shigeo Iijima |
| Pediatrics & Neonatology.2021;62(6)581 |
| [DOI] |
|
| 5 | Myasthenia gravis during pregnancy: what care should be taken? | |
| Renata Dal-Prá Ducci,Cláudia Suemi Kamoi Kay,Otto Jesus Hernandez Fustes,Lineu Cesar Werneck,Paulo José Lorenzoni,Rosana Herminia Scola |
| Arquivos de Neuro-Psiquiatria.2021;79(7)624 |
| [DOI] |
|
| 6 | Neurocritical Care of the Pregnant Patient | |
| Deepa Malaiyandi,Elysia James,Lindsay Peglar,Nurose Karim,Nicholas Henkel,Kristin Guilliams |
| Current Treatment Options in Neurology.2021;23(7)624 |
| [DOI] |
|
| 7 | A Complicated Case of Postpartum Myasthenic Crisis | |
| Ryan Quigley,Zachary A Koenig,Samuel Schick,Erin Miller |
| Cureus.2021;23(7)624 |
| [DOI] |
|
| 8 | Myasthenia gravis and covid-19 in pregnancy: a review of the literature and case series report | |
| Konstantsa Krassimirova Neykova,Milena Milanova,Peter Nikolaev Ignatov |
| The Journal of Maternal-Fetal & Neonatal Medicine.2022;35(25)8308 |
| [DOI] |
|
| 9 | Myasthenia gravis and covid-19 in pregnancy: a review of the literature and case series report | |
| Andrew R. Carey |
| The Journal of Maternal-Fetal & Neonatal Medicine.2021;35(25)251 |
| [DOI] |
|
| 10 | Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody–Positive Generalized Myasthenia Gravis | |
| James F. Howard,John Vissing,Nils E. Gilhus,M. Isabel Leite,Kimiaki Utsugisawa,Petra W. Duda,Ramin Farzaneh-Far,Hiroyuki Murai,Heinz Wiendl |
| Expert Opinion on Investigational Drugs.2021;30(5)483 |
| [DOI] |
|
